Current disease status-Recurrent leukemia Posts on Medivizor
Navigation Menu

Current disease status-Recurrent leukemia Posts on Medivizor

The effects of blinatumomab in patients with relapsed or unresponsive acute lymphoblastic leukemia in outside of clinical trials

Posted by on Feb 24, 2020 in Leukemia | 0 comments

In a nutshell The study evaluated the safety and effectiveness of blinatumomab (Blincyto) in patients with relapsed or unresponsive B-acute lymphoblastic leukemia (B-ALL) outside of clinical trials. The authors found that blinatumomab was safe and effective to treat such patients in real-world medical practice. Some background Relapsed...

Read More

Minimal residual disease response leading to better outcomes for patients with relapsed/refractory acute lymphoblastic leukemia after treatment with blinatumomab

Posted by on Dec 7, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to evaluate the relationship between minimal residual disease response and outcomes in patients with relapsed/unresponsive B-cell precursor acute lymphoblastic leukemia who were treated with blinatumomab.   This study concluded that achieving minimal residual disease response leads to better outcomes for...

Read More

Searching for patients with different types of leukemia to test modified stem cell transplants donated by relatives

Posted by on Sep 20, 2019 in Leukemia | 0 comments

In a nutshell This trial is examining the effectiveness of modified stem cell transplants (SCT) donated by patient relatives, which have certain immune cells removed to prevent transplant rejection in patients with leukemia and lymphoma. The main outcome will be the maximum dose of SCT that can be given safely and is effective. This study is recruiting...

Read More

Evaluating the safety and effectiveness of the Shingrix vaccine for patients with leukemia or lymphoma

Posted by on Aug 23, 2019 in Leukemia | 0 comments

In a nutshell This study evaluated the safety and effectiveness of the herpes zoster vaccine (Shingrix) in patients with blood cancer who are receiving anti-cancer therapy. This study concluded that the Shingrix vaccine was effective in these patients, with manageable side effects. Some background Shingles is caused by a virus called herpes zoster....

Read More

The effects of stem cell transplant on multiple relapses in acute myeloid leukemia.

Posted by on Jul 18, 2019 in Leukemia | 0 comments

In a nutshell This study analyzed the outcomes of allogeneic stem cell transplantation (alloSCT) in patients with acute myeloid leukemia (AML) who had experienced multiple relapses. The main finding was that those who received alloSCT while in complete remission for at least the third time had the best survival.   Some background Complete...

Read More

Dasatinib second and third-line treatment in chronic phase chronic myeloid leukemia

Posted by on Jul 9, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the effectiveness and safety of dasatinib as a second- and third-line therapy in patients with chronic phase chronic myeloid leukemia (CP-CML).  This study concluded that dasatinib was effective as a second-line treatment in these patients but showed limited effectiveness as a third-line treatment....

Read More

Blinatumomab vs chemotherapy in the treatment of relapsed or unresponsive acute lymphoblastic leukemia

Posted by on Jun 23, 2019 in Leukemia | 0 comments

In a nutshell This study compared the safety and effectiveness of blinatumomab (Blincyto) with chemotherapy in the treatment of acute lymphoblastic leukemia (ALL). Researchers found the survival was higher with blinatumomab than chemotherapy alone. Some background Patients with unresponsive or relapsed ALL treated with chemotherapy have...

Read More

Looking for patients with Ph+ or BCR-ABL+ acute lymphoblastic leukemia to test a treatment combination

Posted by on Jun 14, 2019 in Leukemia | 0 comments

In a nutshell This phase 2 trial is evaluating the effectiveness of ponatinib (Iclusig) plus chemotherapy for patients with acute lymphoblastic leukemia (ALL) that is positive for the Philadelphia chromosome (Ph+) or the BCR-ABL gene (BCR-ABL+). The main outcome to be measured will be the number of patients who respond to treatment. This study is...

Read More

Outcomes of stem cell transplant for patients with acute lymphoblastic leukemia after inotuzumab ozogamicin treatment

Posted by on Jun 5, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the outcomes of allogeneic stem cell transplant (allo-SCT) after treatment with inotuzumab ozogamicin (Besponsa) for patients with relapsed/unresponsive acute lymphoblastic leukemia (ALL). This study concluded that allo-SCT provided optimal long-term survival benefit for these patients. Some...

Read More